Pricing Log in Create free account

Tango Therapeutics, Inc. (TNGX) vs Viking Therapeutics, Inc. (VKTX)

Tango Therapeutics, Inc. and Viking Therapeutics, Inc. are both Biotechnology companies. Tango Therapeutics, Inc. is the larger, with a market value of $3.8B against $3.5B — 1.1× the size. Across the 10 metrics below, Tango Therapeutics, Inc. leads on 8 and Viking Therapeutics, Inc. on 2.

Valuation

Metric TNGX VKTX Biotechnology median
P/E n/m n/m 8.50
P/S 52.95 n/m 9.71
P/B 3.22 7.17 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 36.70 n/m 9.21
Earnings yield (3.81%) (18.51%) (33.15%)
Free cash flow yield (4.37%) (14.30%) (25.50%)

Profitability

Metric TNGX VKTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (21.34%) (88.85%) (56.36%)
Return on assets (18.86%) (79.24%) (48.04%)
Return on invested capital (808.35%) 0.00% 0.00%

Growth

Metric TNGX VKTX Biotechnology median
Revenue growth (TTM) 48.29% — 6.02%
EPS growth (last fiscal year) 26.89% (215.84%) 30.26%
Revenue growth, 5-year CAGR 52.13% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TNGX VKTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 50.82 4.72 4.72
Net debt to EBITDA 3.08 1.76 0.96

Dividend

Metric TNGX VKTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric TNGX VKTX Biotechnology median
Market cap 3.83b 3.48b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack